KMSTF

KADIMASTEM LTD NEW by KADIMASTEM LTD. (KMSTF)

About KADIMASTEM LTD NEW by KADIMASTEM LTD. (KMSTF)

Kadimastem Ltd. engages in developing cell therapy in the field of regenerative medicine. It develops a platform for the development and production of embryonic stem cells and various engineered pluripotent stem cells for the purpose of developing cell drugs as off-the-shelf products in the field of regenerative medicine. The company was founded by Yossi Ben Yosef and Michel Revel on October 6, 2008 and is headquartered in Ness Ziona, Israel.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.10
52 Week Low
$0.64
Market cap
21.2M
Dividend yield
0.00%
Volume
--
Avg. volume
263
P/E ratio
-8.20

KADIMASTEM LTD NEW by KADIMASTEM LTD. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.10
52 Week Low
$0.64
Market cap
21.2M
Dividend yield
0.00%
Volume
--
Avg. volume
263
P/E ratio
-8.20